ABSTRACT Somatic cell hybrids between mouse and human cell lines have been used to identify the specific chromosome that governs the synthesis of type I procollagen.
to separate collagen and type I and type III procollagen. Human type I procollagen was assayed by double immunodiffusion analysis with type I procollagen antibodies prepared by immunizing rabbits with urified human type I procollagen. These analyses combined wi karyolc gy and isozyme analyses of each hybrid line have produced evidence for the assignment of the gene for human type I procollagen to chromosome 17. A human microcell-mouse hybrid cell line containing only human chromosome 17 was positive for human type I procollagen, lending further support to the assignment of the human type I procollagen gene to chromosome 17. Finally, by using a hybrid line containing only the long arm of human chromosome 17 translocated onto a mouse chromosome, the type I procollagen gene can be assigned more specifically to the long arm of chromosome 17. Collagen is one of the most abundant proteins in higher animals, occurring in the extracellular matrix as insoluble fibers. This connective tissue protein accounts for a large part of the organic mass of skin, tendon, blood vessels, bone, testes, cornea, and vitreous humor (for reviews, see refs. [1] [2] [3] . The molecular composition of collagen is now well established and at present at least four genetically distinct species of collagen have been identified in human and other mammalian species (3) .
It is now well known that collagen is initially synthesized as a high molecular weight precursor, procollagen (4) . This molecule undergoes several post-translational modification sequences such as hydroxylation of select prolyl and lysyl residues, glycosylation of select hydroxylysyl residues, and cleavage of the terminal extensions from the secreted procollagen molecule. Finally, lysine-derived aldehydes are formed, resulting in crosslinking of collagen fibrils (5) . Each of these particular steps is enzyme mediated and thus offers many opportunities for errors in either the synthesis of the type of collagen or one or more of the post-translational modification systems; these errors occur in several inheritable collagen disorders (6) (7) (8) (9) (10) .
The use of tissue culture in the study of procollagen/collagen synthesis in different cell lines has been shown by Church et al. (11) (12) (13) (14) to be one of the best ways to understand the various post-translational modification sequences involved in collagen biosynthesis. Church and Tanzer recently (14) reported the successful purification of type I procollagen from human skin fibroblasts.
Because of the extreme importance of different collagens during the development and maintenance of structural form in humans, it is of interest to determine the specific chromosome(s) that govern the synthesis of various collagens and their modification enzymes. The technique of somatic cell hybridization has been used in mapping a large number of human genes (15, 16) . This technique involves the fusion of human and rodent cells to form hybrid cell lines that preferentially eliminate human chromosomes. An assay able to distinguish the homologous gene products of the parental lines allows gene assignments to be made by correlating the expression of a human phenotype with the presence of a particular human chromosome. Recently it has become possible to introduce single or small numbers of rodent chromosomes into mammalian cells by fusing microcells (subcellular particles with a decreased amount of nuclear material) with whole cells (17) . A method for the production of human microcells has also been described (18) . The (20, 21) are given in Table 1 . Hybridization was facilitated with Sendai virus inactivated by f3-propiolactone (22, 23 field (25) . Cells were collected by centrifugation, washed with phosphate-buffered saline, and stored as pellets at -90°to be used later for isozyme analyses. Extracts from the frozen cells were analyzed by starch gel electrophoresis (26) to differentiate human and mouse isozymes (27) . Chromosomal preparations of the mouse-human hybrid clones were analyzed by quinacrine and alkaline Giemsa differential staining procedures (28) to identify the human chromosomes present in each hybrid clone. Preparation of Human Microcell Hybrid Cell Lines. Human HeLa S3 microcells were prepared by a modification of the procedure of Schor et al. (18) . HeLa S3 cells were arrested in S phase by the addition of 2.5 mM thymidine to the culture medium of logarithmically growing cells for 23 hr. The medium was then removed from the plates, the cell layer was rinsed once, and fresh medium plus 10% fetal bovine serum was added. Subdivision by extrusion (29) was induced by mitotically arresting the cultures in a pressure chamber with 5 atmospheres (1.065 X 105 Pa) of nitrous oxide for 34 hr. After this prolonged arrest, 33% of the cells had divided by extrusion, resulting in clusters of microcells. Whole cells and microcell clusters were centrifuged at 1000 X g for 15 min and resuspended in 2 ml of 0.5% bovine serum albumin (fraction V, Sigma) in phosphatebuffered saline. Microcell clusters were dispersed by gentle pipetting. The resulting crude preparation, consisting of 68% microcells, was purified by unit gravity sedimentation on a linear 1-3% bovine serum albimiin gradient with a total volume of 50 ml (30) . After sedimentation for 3 hr at room temperature, the gradient was fractionated, and nucleated particles were analyzed by phase microscopy. The top 15 ml of the gradient was found to be composed predominantly of microcells, with less than 1% whole cell contamination. This fraction of microcells was centrifuged at 1000 X g for 12 min, resuspended in 0.5 ml of medium, and used immediately for fusion.
The purified human microcells (2. human type I procollagen by double immunodiffusion with agar slides and antibody to purified type I procollagen. The standard human line NHB gave a strong reaction when carried through this procedure (Fig. 1, well 6 ). Neither mouse parent demonstrated immunoreactivity when tested by this same procedure, although mouse types I and III procollagens were being produced (not shown). Moreover, human type I procollagen antibody did not crossreact with human type III procollagen (Fig. 1, well 5 ).
In the other procedure used to test for human type I procollagen, the [3H]proline-labeled procollagen fraction from each of the hybrid cell lines was purified, type I and type III procollagens were separated by DEAE-cellulose chromatography, and the purified material was assayed by double immunodiffusion in agar slides against human type I and type III antibodies. Fig. 2 presents the chromatographic separation of purified collagenous protein from three hybrid clones: AIM 8a, JFA 16a-8, and WL II 24a-2a. tions 60-80) was found to be type I procollagen at a purity of about 95% as judged by collagenase sensitivity. The pooled fractions were dialyzed against phosphate buffer and tested by double immunodiffusion with NHB type I procollagen antiserum. Purified type I peaks from the representative hybrids showed immunoprecipitation bands (Fig. 1, wells 1, 2 , and 3). Table 2 lists the hybrid cell lines assayed for human type I procollagen along with their human chromosome constitutions and their expression of human isozymes. Also included in Table  2 is the presence or absence of human type I procollagen in each hybrid cell line. Only chromosome 17 showed a strong correlation with type I procollagen production, having complete concordance and no discordant cell lines. One cell line, JFA 14b, initially gave a positive reaction for type I procollagen production and had chromosomes 5, 17, and 18 . Later studies with this cell line demonstrated a loss of type I procollagen production concomitant with the loss of human chromosome 17 from this cell line.
Two additional cell lines were assayed for human type I procollagen. Chromosome analysis of the human microcell hybrid cell line TMSIII-2a by the alkaline Giemsa differential staining procedure revealed a single human submetacentric chromosome in 82% of the cells (Fig. 3) , with 4% of the population apparently possessing two copies of this chromosome. Sequential Giemsa banding-Hoechst centromeric staining (32) identified only human chromosome 17 in this cell line (Fig. 3  inset) , again with a small percentage of the cells possessing two copies of human chromosome 17. The cell line WL II 24a-2a is a highly segregated clone derived from the fusion of human fetal lung fibroblasts (WI-38) with mouse A9 (HPRT-) cells (33) . The only human chromosome present in this cell line is the long arm of chromosome 17 which has been translocated onto a mouse chromosome. Isozyme analysis of TMSIII-2a and WL II 24a-2a revealed only human GalK, a chromosome 17 marker enzyme. Both TMSIII-2a and WLII 24a-2a were positive for human type I procollagen production.
Cell lines ILII-5, TMSIII-2a, and WL II 24a-2a were grown in 5-bromodeoxyuridine at 30 Ag/ml in order to select for cells that had lost thymidine kinase activity. The thymidine kinase gene has been assigned to human chromosome 17 (16 The present study's use of a specific antibody produced against purified human type I procollagen to examine a series of human-mouse hybrid cell lines has provided evidence for the assignment of the type I procollagen gene to human chromosome 17. The assignment is strengthened by the analysis of the human microcell hybrid cell line containing only human chromosome 17 and producing human type I procollagen. The type I procollagen gene can be assigned more specifically to the long arm of human chromosome 17, because the cell line containing only the long arm of human chromosome 17 was also positive for type I procollagen production. The possibility does exist that our antiprocollagen antibody was produced to only human pro al or pro a2 chains and that our gene assignment is to either pro a chain rather than to the procollagen molecule itself. This possibility would necessitate that "hybrid" procollagen molecules are being formed between mouse and human pro a chains. Alternatively, both the pro al and pro a2 proteins may be coded by genes located on chromosome 17. It is also of interest that no abnormalities involving human chromosome 17 Preliminary studies (C. V. Sundar Raj, F. H. Ruddle, and R. L. Church, unpublished data) have indicated that human type III procollagen and procollagen peptidase segregate independently from type I procollagen and, therefore, the synthesis of each of these proteins must be controlled by separate genes. Further work using somatic cell hybrids will aid in defining the genes involved in the multistep process of collagen biosynthesis as well as provide a means of examining disorders involving connective tissue.
